首页|Axl glycosylation mediates tumor cell proliferation,invasion and lymphatic metastasis in murine hepatocellular carcinoma
Axl glycosylation mediates tumor cell proliferation,invasion and lymphatic metastasis in murine hepatocellular carcinoma
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
万方数据
AIM:To investigate the effects of Axl deglycosylation on tumor lymphatic metastases in mouse hepatocellular carcinoma cell lines.METHODS:Western blotting was used to analyze the expression profile of Axl glycoprotein in mouse hepatocellular carcinoma cell line Hca-F treated with tunicamycin and PNGase F 3-(4,5)-dimethylthiazol(-zyl)-3,5-diphenyltetrazolium bromide (MTT) assay,extracellular matrix (ECM) invasion assay (in vitro) and tumor metastasis assay (in vivo) were utilized to evaluate the effect of Axl deglycosylation on the Hca-F cell proliferation,invasion and lymphatic metastasis.RESULTS:Tunicamycin and PNGase F treatment markedly inhibited Axl glycoprotein synthesis and expression,proliferation,invasion,and lymphatic metastasis both in vitro and in vivo.In the MTT assay,proliferation was apparent in untreated Hca-F cells compared with treated Hca-F cells.In the ECM invasion assay (in vitro),treated cells passed through the ECMatrix gel in significantly smaller numbers than untreated cells (tunicamycin 5 μg/mL:68 ± 8 vs 80 ± 9,P =0.0222; 10μg/mL:50 ± 6 vs 80 ± 9,P =0.0003; 20 lμg/mL:41 ±4 vs 80 ± 9,P =0.0001); (PNGase F 8 h:66 ± 7 vs 82± 8,P =0.0098; 16 h:49 ± 4 vs 82 ± 8,P =0.0001;24 h:34 ± 3 vs 82 ± 8,P =0.0001).In the tumor metastasis assay (in vivo),average lymph node weights of the untreated Hca-F group compared with treated Hca-F groups (tunicamycin 5 μg/mL:0.84 ± 0.21 g vs 0.72 ± 0.19 g,P =0.3237; 10 μg/mL:0.84 ± 0.21 g vs 0.54 ± 0.11 g,P =0.0113; 20 μg/mL:0.84 ± 0.21 g vs 0.42 ± 0.06 g,P =0.0008); (PNGase F 8 h:0.79 ± 0.15 g vs 0.63 ± 0.13 g,P =0.0766; 16 h:0.79 ± 0.15g vs 0.49 ± 0.10 g,P =0.0022; 24 h:0.79 ± 0.15 g vs0.39 ± 0.05 g,P =0.0001).Also,average lymph node volumes of the untreated Hca-F group compared with treated Hca-F groups (tunicamycin 5 μg/mL:815 ± 61mm3 vs 680 ± 59 mm3,P =0.0613; 10 μg/mL:815 ±61 mm3 vs 580 ± 29 mm3,P =0.0001; 20 μg/mL:815± 61 mm3 vs 395 ± 12 mm3,P =0.0001); (PNGase F 8 h:670 ± 56 mm3 vs 581 ± 48 mm3,P =0.0532; 16h:670 ± 56 mm3 vs 412 ± 22 mm3,P =0.0001; 24 h:670 ± 56 mm3 vs 323 ± 11 mm3,P =0.0001).CONCLUSION:Alteration of Axl glycosylation can attenuate neoplastic lymphatic metastasis.Axl N-glycans may be a universal target for chemotherapy.